News - Medicinapersonalizada

The University Hospital of Navarre (HUN) of the Navarre Healthcare System (SNS-O) selected as an affiliated entity for the Network of Comprehensive Cancer Centers of the European Union, a joint action called CraNE, in response to the Flagship Initiative number 5 of the European Board Cancer Plan (EBCP).

Researchers at the University Hospital of Navarre (HUN) will coordinate a cross-sectional, multicenter study on early-onset gastrointestinal cancer, understood as that diagnosed in young patients (under 50 years of age), in whom the incidence of this type of cancer has increased worryingly in recent decades.

The President of Navarre, María Chivite Navascués, has announced an investment of 2.6 million euros to expand the Data Processing Center (DPC) of the Government of Navarre. This investment will double its capacity to consolidate the digitalisation of the services provided to the different departments of the Government of Navarre and to all citizens.

Aimed at companies and research and knowledge dissemination organizations with a work center in Navarra and which will carry out R&D activities in said center during the years 2024-2027.

The Oncoimmunology Unit, headed by researcher David Escors, has been developing since 2008 several studies to advance in immunotherapies against cancer that will result in more effective treatments. The identification of the immunomodulatory capacities of oleuropein, which has been carried out at Navarrabiomed, will allow it to be combined with other treatments to enhance antitumor responses in different types of cancer.

The European Partnership for Personalised Medicine (EP PerMed), supported by the European Union under Horizon Europe (Grant Agreement N° 101137129), launches its first joint transnational call (JTC2024) for proposals on “Identification or Validation of Targets for Personalised Medicine Approaches (PMTargets)”. In total, 38 funding organisations participate in this call with an available budget of over 45 Mio€.